Search Results
Mar 18, 2026, 08:43 ET Lifepoint Health, Eon Release Data Showing Why Identification and Follow-Up of Incidental Findings are Integral to Improving Breast Cancer Diagnosis and Outcomes
care."Lifepoint's Healthy Person ProgramLifepoint's Healthy Person Program is an enterprise initiative across multiple disease areas including lung, pancreas, kidney, liver, thyroid and aortic aneurysms powered by Eon's AI platform. To date, Lifepoint's incidental findings management program — one
More news about: Eon
Mar 18, 2026, 08:17 ET Volition Reports Breakthrough in Liquid Biopsy: Achievement of over 99% Purity in Isolating Cancer DNA
Capture-Seq™ could contribute to multi-cancer early detection and disease management, particularly in combination with Volition's existing Nu.Q® assay for lung cancer (H3K27me3) but potentially in combination with other technologies too."Mr. Gael Forterre, Chief Commercial Officer, Volition added:"This
More news about: VolitionRx Limited
Mar 18, 2026, 08:00 ET Freenome Reports Data for Multiomic Blood-Based Screening Test for Lung Cancer
tests, today announced initial development data for its investigational lung cancer screening test. The data demonstrate the potential of a multiomics approach that combines DNA methylation analysis and protein markers to detect lung cancer in high-risk individuals.
More news about: Freenome Holdings, Inc.
Mar 18, 2026, 07:44 ET Jazz Pharmaceuticals to Present Compelling Clinical and Pre-Clinical Data Advancing Oncology Research at AACR 2026
research evaluating imiprodones, inclusive of dordaviprone (formerly ONC201) and JZP3507 (formerly ONC206), across renal cell carcinoma and small-cell lung cancer models, including combination approaches and comparative analyses to further characterize activity and mechanism.Additional presentations
More news about: Jazz Pharmaceuticals plc
Mar 18, 2026, 07:00 ET Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2026 AACR Annual Meeting
advance our understanding of TUSC2's therapeutic mechanisms and its impact on lung cancer. Additionally, the identification of TROP2 and PTEN as potential biomarkers of response to TUSC2 gene therapy in non-small cell lung cancer is a pivotal development, providing insights that could refine patient
More news about: Genprex, Inc.
Mar 18, 2026, 06:00 ET IDEAYA Biosciences Announces Upcoming Presentations at AACR 2026 Highlighting Multiple Clinical Stage Pipeline Programs
studies to evaluate safety, tolerability, PK and efficacy of these three programs across a broad range of large solid tumor indications, including lung, colorectal, pancreatic, breast, and prostate cancer.
More news about: IDEAYA Biosciences, Inc.
Mar 17, 2026, 20:43 ET 【AACR 2026】亞盛醫藥宣佈將在2026年美國癌症研究協會年會上公佈四項最新臨床前進展
Embryonic ectoderm development (EED) inhibitor APG-5918 synergizes with topoisomerase I inhibitors in preclinical small-cell lung cancer (SCLC) models through epigenetic priming of chemosensitivity胚胎外胚層發育蛋白（EED
More news about: 亞盛醫藥
Mar 17, 2026, 20:30 ET Antengene to Present on Three Preclinical Programs at AACR 2026, Highlighting Next-Generation ADCs and AnTenGager™ TCEs
documents subsequently submitted to the Hong Kong Stock Exchange.For more information, please contact:Investor Contacts: Donald LungE-mail: [email protected] BD Contacts: Ariel
More news about: Antengene Corporation Limited
Mar 17, 2026, 19:00 ET Breakthrough at 2026 AACR! Senhwa Biosciences' CX-5461 Enters the Field of Photodynamic Therapy, Opening a New Indication Strategy
relatively low systemic toxicity. PDT has already been applied in a range of diseases, including skin cancers, head and neck cancer, esophageal cancer, lung cancer, bladder cancer, and cervical cancer.Market research also indicates continued growth in the global photodynamic therapy market. The oncology-focused
More news about: Senhwa Biosciences, Inc.
Mar 17, 2026, 18:47 ET Brayton Purcell LLP Responds to San Jose Mercury News Investigation Highlighting Bay Area Silicosis Crisis Tied to Crystalline Silica Artificial Stone
artificial stone, with more than 50 requiring lung transplants and 29 deaths documented. Dr. Sheiphali Gandhi, an occupational‑disease specialist at UC San Francisco who has treated dozens of affected workers, said:"I see people with an incurable lung disease that was preventable. It's frustrating.
More news about: Brayton Purcell LLP
Mar 17, 2026, 17:15 ET Nuvalent to Present New Preclinical and Clinical Data for Zidesamtinib, an Investigational ROS1-Selective Inhibitor, at AACR Annual Meeting 2026
across all lines of therapy.Based on results for tyrosine kinase inhibitor (TKI) pre-treated patients with advanced ROS1-positive non-small cell lung cancer (NSCLC) enrolled in the global registrational ARROS-1 Phase 1/2 clinical trial, the U.S. Food and Drug Administration (FDA) has accepted for
More news about: Nuvalent, Inc.
Mar 17, 2026, 16:35 ET Nuvation Bio to Present Pivotal IBTROZI® (Taletrectinib) Data in TKI-Naïve and TKI-Pretreated Patients with Advanced ROS1-Positive Non-Small Cell Lung Cancer at AACR 2026
Meeting.About ROS1+ NSCLCEach year, more than one million people globally are diagnosed with non-small cell lung cancer (NSCLC), the most common form of lung cancer. It is estimated that approximately 2% of patients with NSCLC have ROS1+ disease. About 35% of patients newly diagnosed
More news about: Nuvation Bio Inc.
Mar 17, 2026, 09:01 ET Co-PSMA data presented at EAU Annual Congress 2026 with manuscript accepted for publication in the European Urology journal
extra-pelvic lymph nodes Bone Viscera (lung)11/50 (22%)4/50
More news about: Clarity Pharmaceuticals
Mar 17, 2026, 08:30 ET IceCure Reports 2025 Full Year Financial & Operational Results
cryoablation therapy systems for the destruction of tumors (benign and cancerous) by freezing, with the primary focus areas being breast, kidney, bone and lung cancer. Its minimally invasive technology is a safe and effective option to surgical tumor removal that is easily performed in a relatively short procedure.
More news about: IceCure Medical
Mar 17, 2026, 07:43 ET Cereno Scientific Receives Approval to Initiate FDA-aligned Phase I Pharmacokinetic Study of CS014 Supporting Phase II Development in PH-ILD
supports a streamlined and capital-efficient development pathway toward the planned Phase II trial in pulmonary hypertension associated with interstitial lung disease (PH-ILD) in Q1 2027. The approved study is a Phase I, open-label, randomized, two-period crossover pharmacokinetic (PK) trial in
More news about: Cereno Scientific
Mar 17, 2026, 07:39 ET Cereno Scientific Receives Approval to Initiate FDA-aligned Phase I Pharmacokinetic Study of CS014 Supporting Phase II Development in PH-ILD
supports a streamlined and capital-efficient development pathway toward the planned Phase II trial in pulmonary hypertension associated with interstitial lung disease (PH-ILD) in Q1 2027. The approved study is a Phase I, open-label, randomized, two-period crossover pharmacokinetic (PK) trial in
More news about: Cereno Scientific
Mar 17, 2026, 07:30 ET Pixelgen Technologies and Andreas Lundqvist's Research Group at Karolinska Institutet Collaborate to Identify Novel Biomarkers for Cancer Immunotherapy
Lundqvist's group will use Pixelgen's Proximity Network Assay to explore spatial distribution and abundance of single cell surface proteins in non-small cell lung cancerSTOCKHOLM, March 17, 2026 /PRNewswire/ --
More news about: Pixelgen Technologies
Mar 17, 2026, 03:45 ET Fractal Introduces LLM Studio to Bring Enterprise-Grade GenAI Customization with NVIDIA NeMo and NVIDIA NIM Microservices
Qure.ai, a global healthcare AI leader enhancing the rapid identification and management of tuberculosis, lung cancer, and stroke. Fractal's dedicated AI Research team is focused on foundational
More news about: Fractal
Mar 17, 2026, 03:31 ET Fractal Introduces LLM Studio to Bring Enterprise-Grade GenAI Customization with NVIDIA NeMo and NVIDIA NIM Microservices
Qure.ai, a global healthcare AI leader enhancing the rapid identification and management of tuberculosis, lung cancer, and stroke. Fractal's dedicated AI Research team is focused on foundational
More news about: Fractal
Mar 16, 2026, 21:11 ET Brayton Purcell LLP Applauds National Spotlight on Artificial Stone Silicosis Crisis Following New York Times Investigation
debilitating when it progresses. It always progresses. And there is no real treatment." She has evaluated hundreds of workers who developed permanent lung damage after fabricating artificial stone countertops.The article also highlights testimony from Dr. David Michaels, epidemiologist and
More news about: Brayton Purcell LLP
Mar 16, 2026, 16:32 ET Function to Enable Members to Securely Connect with Microsoft Copilot Health, Expanding Personalized Health Across AI Tools
people. The advanced MRI scans for signals of cancers, unruptured aneurysms, endometriosis, stroke, and more, while the CT scan can search for signals of lung cancer, plaque in the heart, and other serious health conditions. Function is redefining what it means to take control of your health.
More news about: Function Health
Mar 16, 2026, 14:57 ET Lung Cancer Group Outlines How 2026 EPA Actions Could Shape Asbestos-Related Lung Cancer Claims
history from decades ago."Lung Cancer Group is an informational resource focused on helping families understand how asbestos causes lung cancer, what health care options can help, and why compensation may be available. For more information, visit Lung Cancer Group's
More news about: Lung Cancer Group
Mar 16, 2026, 10:20 ET Laronix Launches Voice Restoration Study for ICU Patients at Greater Baltimore Medical Center
and beyond. Laronix's FDA-registered artificial larynx medical device, MIRA Voice mimics human voice generation using a computer-controlled artificial lung and synthetic vocal folds, offering customizable male and female voices.About GBMC HealthCareSince its founding in 1965, GBMC has
More news about: Laronix, Inc.
Mar 15, 2026, 22:05 ET Akeso Announces Global First-in-Class Trispecific Antibody AK150 Enters Clinical Trials: A Triple-Target Approach to Overcome Immunotherapy Resistance
levels in various solid tumors, particularly prominent in tumor types with significant immunosuppressive microenvironments, including non-small cell lung cancer, hepatocellular carcinoma, pancreatic cancer, and some refractory breast cancers. Although current single- or dual-target therapies against macrophage
More news about: Akeso, Inc.
Mar 15, 2026, 02:03 ET Spring Into Healthy Breathing: Varon Offers Tips for Travel and Wellness with Oxygen Support
Hydrated – Proper hydration keeps airways moist and supports oxygen absorption. Exercise Smartly – Light outdoor activity enhances lung capacity and circulation; monitor oxygen levels when trying new routines. Travel Preparedness – Fully charge your portable
More news about: Varon oxygen concentrator